StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Calidi Biotherapeutics's enterprise value was -$2.62M on Nov 11, 2026, against $157.23M a year earlier. Over the last 5 years it ranged from -$3.80M to $44.16B, with a median of $1.47B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$2.62M-102.2%
2025Dec 31, 2025$119.66M-94.2%
2024Dec 31, 2024$2.06B-80.0%
2023Dec 29, 2023$10.27B+27.4%
2022Dec 30, 2022$8.06B–

More Calidi Biotherapeutics figures

See a number that looks wrong?